Lokaltherapie chronischer Wunden bei Patienten mit den ... - AWMF

S3-Leitlinie 091-001 „Lokaltherapie chronischer Wunden bei den Risiken CVI, PAVK und Diabetes mellitus“
301. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a
collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of
diabetic foot ulcers. Archives of surgery (Chicago, Ill : 1960). 2002;137(7):822-7. Epub 2002/07/03.
302. Barber C, Watt A, Pham C, Maddern G, Penington A, Mutimer K, et al. Bioengineered skin
substitutes for the management of wounds: a systematic review. Report. 2006:118.
303. Donaghue VM, Chrzan JS, Rosenblum BI, Giurini JM, Habershaw GM, Veves A. Evaluation of a
collagen-alginate wound dressing in the management of diabetic foot ulcers. Adv Wound Care.
1998;11(3):114-9. Epub 1998/09/08.
304. Abbruzzese L, Rizzo L, Fanelli G, Tedeschi A, Scatena A, Goretti C, et al. Effectiveness and
safety of a novel gel dressing in the management of neuropathic leg ulcers in diabetic patients: a
prospective double-blind randomized trial. International Journal of Lower Extremity Wounds.
2009;8(3):134-40.
305. Steed DL, Webster MW, Ricotta JJ, Luterman A, Brown S, Comerota AJ, et al. Clinical
evaluation of recombinant human platelet-derived growth factor for the treatment of lower
extremity diabetic ulcers. Journal of Vascular Surgery. 1995;21(1):71-81.
306. Robson MC, Payne WG, Garner WL, Biundo J, Giacalone VF, Cooper DM, et al. Integrating the
results of phase IV (post-marketing) clinical trial with four previous trials reinforces the position that
Regranex (becaplermin) gel 0.01% is an effective adjunct to the treatment of diabetic foot ulcer. J
Appl Res. 2005;5:35-45.
307. Buchberger B, Follmann M, Freyer D, Huppertz H, Ehm A, Wasem J. The importance of
growth factors for the treatment of chronic wounds in the case of diabetic foot ulcers (Structured
abstract). Cologne: German Agency for Health Technology Assessment at the German Institute for
Medical Documentation and Information (DAHTA DIMDI), 2010.
308. Buchberger B, Follmann M, Freyer D, Huppertz H, Ehm A, Wasem J. The importance of
growth factors for the treatment of chronic wounds in the case of diabetic foot ulcers. GMS Health
Technol Assess. 2010;6:Doc12.
309. Wieman TJ. Efficacy and safety of recombinant human platelet-derived growth factor-BB
(becaplermin) in patients with chronic venous ulcers: a pilot study. Wounds: A Compendium of
Clinical Research and Practice. 2003;15(8):257-64.
310. Janssen Cilag Gmb H. Rote Hand Brief zu Regranex (Becaplermin): Jannsen Cilag GmbH; 2010.
311. Wenzel J, Gerdsen R, Phillipp-Dormston W, Bieber T, Uerlich M. Topical treatment of
pyoderma gangraenosum. Dermatology. 2002;205(3):221-3.
312. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains
elevated levels of metalloproteinases MMP-2 and MMP-9. JInvest Dermatol. 1993;101(1):64-8.
313. Halcon L, Milkus K. Staphylococcus aureus and wounds: a review of tea tree oil as a promising
antimicrobial. AmJInfectControl. 2004;32(7):402-8.
314. Gloor M, Hauth A, Gehring W. O/W emulsions compromise the stratum corneum barrier and
improve drug penetration. Pharmazie. 2003;58(10):709-15.
315. Falanga V. Care of venous leg ulcers. OstomyWoundManage. 1999;45(1A Suppl):33S-43S.
316. Schuren J, Becker A, Sibbald RG. A liquid film-forming acrylate for peri-wound protection: a
systematic review and meta-analysis (3M Cavilon no-sting barrier film). International Wound Journal.
2005;2(3):230-8.
317. Cameron J, Hoffman D, Wilson J, Cherry G. Comparison of two peri-wound skin protectants in
venous leg ulcers: a randomised controlled trial. JWound Care. 2005;14(5):233-6.
318. Rolstad BS, Borchert K, Magnan S, Scheel N. A comparison of an alcohol-based and a
siloxanebased peri-wound skin protectant. J Wound Care. 1994;3(8):367-8.
319. Neander KD, Hesse F. The protective effects of a new preparation on wound edges. JWound
Care. 2003;12(10):369-71.
320. Dunning G. Emollients: application of topical treatments to the skin. BrJNurs.
2007;16(21):1342-5.
321. Korner A, Dinten-Schmid B, Stoffel L, Hirter K, Kappeli S. [Skin care and skin protection in
preterm babies]. Pflege. 2009;22(4):266-76.
Seite 269 von 279 aktueller Stand: 12.06.2012